NY S07918

Clinicians prescribing Schedule II prescription narcotic drugs must conduct baseline urine drug testing prior to issuing initial prescriptions to assess new patients and detect non-prescribed drug use.

Initial prescriptions limited to four-day supplies until confirmatory or quantitative drug testing results (such as liquid chromatography-mass spectrometry) are obtained.

Ongoing periodic testing required at minimum twice annually for all patients; patients treated for addiction must be tested as frequently as necessary to ensure therapeutic adherence.

Department of Health directed to ensure reimbursement by clinical health care providers and laboratories for confirmatory and quantitative chromatographic drug testing methodologies.

Act takes effect 60 days after becoming law.